Discussion on Rockefeller medicine, OxyContin, Sackler family, and Supreme Court ruling

This chapter explores the promotion of a shrinking population, the approval of OxyContin by the FDA in connection to financial events and predatory practices, and legal tactics employed by the Sackler family to address opioid-related lawsuits through bankruptcy court.